News


All News

Although there is a lot of ongoing research into rosacea and a number of FDA-approved medications, very little of either have to do with skin of color. Research protocols have not included ethnic skin, and medications were approved before the FDA required the inclusion of ethnic subjects.

Some research has demonstrated efficacy with the off-label use of tumor necrosis factor-alpha in treating inflammatory skin conditions such as pyoderma gangrenosum and hidradenitis suppurativa. The use of infliximab, in particular, has resulted in disease quiescence in patients who had either condition, and its use has demonstrated a steroid-sparing effect in patients with pyoderma gangrenosum.

Several ingredients found in topical preparations help treat dry skin and the subsequent symptom of pruritus. The results of a recent study with dihydroavenanthramide D demonstrate the agent is very effective in the treatment of pruritus, and according to one expert, should be considered an option when trying to treat and subdue pruritic symptoms.

Allergic contact dermatitis is a cell-mediated condition in which natural killer T cells act both locally in the skin and systemically. Researchers have identified a novel transcription factor that regulates the molecule that natural killer T cells recognize when they migrate into the skin. The finding points to a new pharmacological target in the treatment of allergic contact dermatitis.

Etanercept is effective in treating psoriasis in the pediatric population, a study has found. The research also found that patients in the study had increased levels of C-reactive protein, an inflammatory marker that may be elevated as a result of abdominal obesity.

National report - Gardasil presents no significant safety concerns. That was the consensus of a Center for Disease Control (CDC) advisory committee following a review of safety studies of the human papillomavirus quadrivalent vaccine, manufactured by Merck, two years post-approval by the Food and Drug Administration (FDA).

Wilmington, Mass. - Dusa Pharmaceuticals has stopped developing Levulan photo dynamic therapy for acne, after mid-stage trials failed to show statistically significant results.

Chicago - From the sexual proclivities of senior citizens to the continuing spread of HIV, the state of sexually transmitted diseases (STDs) worldwide is more dire than casual observers would guess, says one expert.

Las Vegas - When it comes to office efficiency and patient management, experts’ advice runs the gamut, from choosing patient-friendly palliative care to properly using physician extenders.

Las Vegas - The most common diagnosis of cutaneous T-cell lymphoma diagnosis in the practice of dermatology is mycosis fungoides (MF), according to Peter W. Heald, M.D., professor of dermatology, Yale School of Medicine, New Haven, Conn., who spoke here at the 27th Annual Fall Clinical Dermatology Conference.

Melanoma update

Las Vegas - One American dies from malignant melanoma every hour, according to Darrell S. Rigel, M.D., M.S., co-director of the 27th Annual Fall Clinical Dermatology Conference, and clinical professor of dermatology, New York University School of Medicine, New York.

Las Vegas - A meticulous history and scalp examination are key in diagnosing and managing hair loss in women, says Jerry Shapiro, M.D., F.R.C.P.C., department of dermatology, New York University, New York, and department of dermatology and skin science, University of British Columbia, Vancouver, Canada, in a presentation at the Fall Clinical Dermatology Conference here.